Calix (CALX)
(Delayed Data from NYSE)
$29.56 USD
+0.28 (0.96%)
Updated Apr 22, 2024 04:00 PM ET
After-Market: $25.15 -4.41 (-14.92%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Income Statements
Fiscal Year end for Calix, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 1,040 | 868 | 679 | 541 | 424 |
Cost Of Goods | 521 | 432 | 323 | 274 | 236 |
Gross Profit | 518 | 435 | 357 | 267 | 188 |
Selling & Adminstrative & Depr. & Amort Expenses | 493 | 383 | 283 | 230 | 203 |
Income After Depreciation & Amortization | 26 | 53 | 74 | 37 | -15 |
Non-Operating Income | 9 | 1 | -1 | -1 | 0 |
Interest Expense | 0 | 0 | 0 | 2 | 1 |
Pretax Income | 35 | 54 | 73 | 34 | -17 |
Income Taxes | 5 | 13 | -166 | 1 | 1 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 29 | 41 | 238 | 33 | -18 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 29 | 41 | 238 | 33 | -18 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 38 | 66 | 89 | 51 | -5 |
Depreciation & Amortization (Cash Flow) | 12 | 13 | 15 | 14 | 10 |
Income After Depreciation & Amortization | 26 | 53 | 74 | 37 | -15 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 69.32 | 68.91 | 67.86 | 62.00 | 54.99 |
Diluted EPS Before Non-Recurring Items | 0.83 | 0.61 | 1.10 | 0.75 | -0.14 |
Diluted Net EPS (GAAP) | 0.42 | 0.60 | 3.51 | 0.54 | -0.32 |
Fiscal Year end for Calix, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 264.73 | 263.84 | 261.02 | 250.01 |
Cost Of Goods | NA | 151.49 | 123.29 | 124.55 | 121.96 |
Gross Profit | NA | 113.25 | 140.55 | 136.47 | 128.05 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 125.34 | 124.62 | 124.66 | 118.11 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -12.09 | 15.93 | 11.81 | 9.94 |
Non-Operating Income | NA | 3.07 | 2.21 | 2.42 | 1.47 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -9.02 | 18.14 | 14.23 | 11.41 |
Income Taxes | NA | -2.43 | 1.19 | 4.86 | 1.81 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -6.60 | 16.95 | 9.37 | 9.60 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -6.60 | 16.95 | 9.37 | 9.60 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 65.32 | 69.58 | 69.66 | 69.86 |
Diluted EPS Before Non-Recurring Items | NA | 0.28 | 0.25 | 0.15 | 0.15 |
Diluted Net EPS (GAAP) | NA | -0.09 | 0.24 | 0.13 | 0.14 |